V V Tertov - JoVE Visualize

Showing results (101-110 of 127) with videos related to

Pageof 13

Sort By:

Circulation Research|July 1, 1992

Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregationV V Tertov, A N Orekhov, I A Sobenin, et al.

Atherosclerosis|April 1, 1993

Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cellsI A Sobenin, V V Tertov, T Koschinsky, et al.

Tissue & Cell|January 1, 1987

Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aortaV V Tertov, A N Orekhov, Grigorian GYu, et al.

Artificial Organs|December 1, 1986

Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitroA N Orekhov, K A Khashimov, D N Mukhin, et al.

Experimental and Molecular Pathology|February 1, 1985

Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cellsA N Orekhov, V V Tertov, I D Novikov, et al.

Atherosclerosis|April 1, 1990

Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell cultureV V Tertov, A N Orekhov, K S Sayadyan, et al.

Experimental and Molecular Pathology|December 1, 1987

Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cellsV V Tertov, A N Orekhov, S A Kudryashov, et al.

The American Journal of Pathology|April 1, 1984

Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cellsA N Orekhov, I I Karpova, V V Tertov, et al.

Atherosclerosis|July 1, 1992

Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverineA N Orekhov, I V Andrianova, M D Rekhter, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|April 1, 1991

[Atherogenic effect of beta-blocker propranolol revealed in the rabbit denudated aorta]I V Andrianova, M D Rekhter, V V Tertov, et al.

Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:

Pageof 13

Circulation Research|July 1, 1992

Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregationV V Tertov, A N Orekhov, I A Sobenin, et al.

Atherosclerosis|April 1, 1993

Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cellsI A Sobenin, V V Tertov, T Koschinsky, et al.

Tissue & Cell|January 1, 1987

Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aortaV V Tertov, A N Orekhov, Grigorian GYu, et al.

Artificial Organs|December 1, 1986

Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitroA N Orekhov, K A Khashimov, D N Mukhin, et al.

Experimental and Molecular Pathology|February 1, 1985

Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme-isolated and cultured cellsA N Orekhov, V V Tertov, I D Novikov, et al.

Atherosclerosis|April 1, 1990

Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell cultureV V Tertov, A N Orekhov, K S Sayadyan, et al.

Experimental and Molecular Pathology|December 1, 1987

Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cellsV V Tertov, A N Orekhov, S A Kudryashov, et al.

The American Journal of Pathology|April 1, 1984

Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cellsA N Orekhov, I I Karpova, V V Tertov, et al.

Atherosclerosis|July 1, 1992

Beta-blockers: propranolol, metoprolol, atenolol, pindolol, alprenolol and timolol, manifest atherogenicity on in vitro, ex vivo and in vivo models. Elimination of propranolol atherogenic effects by papaverineA N Orekhov, I V Andrianova, M D Rekhter, et al.

Biulleten' Eksperimental'Noi Biologii I Meditsiny|April 1, 1991

[Atherogenic effect of beta-blocker propranolol revealed in the rabbit denudated aorta]I V Andrianova, M D Rekhter, V V Tertov, et al.

Pageof 13